Table 3

Chemotherapy use

Vaccine + chemotherapyPatient no.Drug(s)
1Gliadel wafers
2Temozolamide
3Temozolamide
4Temozolamide
5Temozolamide and irinotecan
6Temozolamide
7Temozolamide and Accutane
8Tamoxifen
9Temozolamide and CCNU
10Temozolamide and Accutane
11Temozolamide and Gleevec
12Temozolamide, procarbazine, CCNU, and vincristine
13Temozolamide, thalidomide, and etoposide
Chemotherapy
1Temozolamide
2Temozolamide
3Temozolamide and procarbazine
4Temozolamide, carboplatin, vincristine, and procarbazine
5Temozolamide, BCNU, and thalidomide
6Temozolamide and procarbazine
7Temozolamide
8Temozolamide and thalidomide
9Gliadel wafers, and vincristine
10Temozolamide, carboplatin, and vincristine
11BCNU and temozolamide
12Gliadel wafers and temozolamide
13BCNU
  • NOTE. Temozolomide standard dose is 150–200 mg/m2 once a day × 5 days every 28 days. BCNU was given 150–200 mg/m2 intravenously every 6 weeks. Gliadel wafers are a timed-release encapsulation of BCNU.

  • Abbreviations: BCNU, 1,3-bis(2-chloroethyl)-1-nitosourea; CCNU, 1-(2-chloroethyl)-3-cyclohexyl-1-nitosourea.